Marketing-authorisation holder · Germany
Grünenthal GmbH
27 medicines in 4 countries, as authorisation holder and manufacturer.
Loading your page…
Loading your page…
Marketing-authorisation holder · Germany
27 medicines in 4 countries, as authorisation holder and manufacturer.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 27
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| MOVENTIGCompressa rivestita con film | Naloxegol | Italy | Authorised | |
| Moventig | Naloxegol | EU (EMA) | Authorised | 2014 |
| Nebido 1000 mg/4 ml otopina za injekcijuotopina za injekciju | Testosterone | Croatia | Marketed | 2025 |
| Nexium 20 mg želučanootporne tableteželučanootporna tableta | Esomeprazole | Croatia | Marketed | 2022 |
| Nexium 40 mg želučanootporne tableteželučanootporna tableta | Esomeprazole | Croatia | Not marketed | 2022 |
| Palexia 100 mg filmom obložene tabletefilmom obložena tableta | Tapentadol | Croatia | Marketed | 2015 |
| Palexia 20 mg/ml oralna otopinaoralna otopina | Tapentadol | Croatia | Marketed | 2015 |
| Palexia 4 mg/ml oralna otopinaoralna otopina | Tapentadol | Croatia | Not marketed | 2015 |
| Palexia 50 mg filmom obložene tabletefilmom obložena tableta | Tapentadol | Croatia | Marketed | 2015 |
| Palexia 75 mg filmom obložene tabletefilmom obložena tableta | Tapentadol | Croatia | Marketed | 2015 |
| Palexia retard 100 mg tablete s produljenim oslobađanjemtableta s produljenim oslobađanjem | Tapentadol | Croatia | Marketed | 2015 |
| Palexia retard 150 mg tablete s produljenim oslobađanjemtableta s produljenim oslobađanjem | Tapentadol | Croatia | Marketed | 2015 |
| Palexia retard 200 mg tablete s produljenim oslobađanjemtableta s produljenim oslobađanjem | Tapentadol | Croatia | Not marketed | 2015 |
| Palexia retard 25 mg tablete s produljenim oslobađanjemtableta s produljenim oslobađanjem | Tapentadol | Croatia | Not marketed | 2015 |
| Palexia retard 250 mg tablete s produljenim oslobađanjemtableta s produljenim oslobađanjem | Tapentadol | Croatia | Not marketed | 2015 |
| Palexia retard 50 mg tablete s produljenim oslobađanjemtableta s produljenim oslobađanjem | Tapentadol | Croatia | Marketed | 2015 |
| PECFENTSpray nasale, soluzione | Fentanyl | Italy | Authorised | |
| QUTENZACerotto cutaneo | Capsaicin | Italy | Authorised | |
| Qutenza | Capsaicin | EU (EMA) | Authorised | 2009 |
| Sancuso | Granisetron | EU (EMA) | Authorised | 2012 |
| SANCUSOCerotto transdermico | Granisetron | Italy | Authorised | |
| Versatis 700 mg ljekoviti flasterljekoviti flaster | Lidocaine | Croatia | Marketed | 2020 |
| Zomig 2,5 mg filmom obložene tabletefilmom obložena tableta | Zolmitriptan | Croatia | Marketed | 2024 |
| Zomig Rapimelt 2,5 mg raspadljive tablete za ustaraspadljiva tableta za usta | Zolmitriptan | Croatia | Marketed | 2024 |
| Duzallo | Allopurinol, Lesinurad | EU (EMA) | Withdrawn | 2018 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Croatia | 17 | 17 | 0 | CompaniesAll medicines |
| European Union (EMA) | 5 | 3 | 2 | CompaniesAll medicines |
| Italy | 4 | 4 | 0 | CompaniesAll medicines |
| Romania | 1 | 0 | 1 | CompaniesAll medicines |
Also in the registers of Brazil, Netherlands, Serbia, Spain, United Kingdom
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: European Medicines Agency (EPAR data).
Licence: EMA reuse policy (source acknowledgement required)
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licence: Otvorena dozvola RH
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_A_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:41 GMT; acquired 2026-10-13T17:21:06.055244+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Report an error or request removalCorrections from the company itself are welcome.
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Ministerul Sănătății, Catalogul public naţional al preţurilor, 18 iunie 2021, downloaded 2026-10-08 from data.gov.ro; CC BY 4.0; structured factual adaptation, code whitespace trimmed only where explicitly recorded.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Licence: Serbian Open Data Licence (sodl)
Other companies in the same group.
Ranked by their number of medicines.